Combined metformin and repaglinide therapy resulted in superior glycemic control compared with repaglinide or metformin monotherapy in patients with type 2 diabetes whose glycemia had not been well controlled on metformin alone. Repaglinide monotherapy was as effective as metformin monotherapy.

The education tool improved healthcare professional confidence, knowledge and may improve the quality of inpatient diabetes care.

The management of raised glucose clinical decision tool resulted in a significant increase in the number of same-calendar-day discharges and reduction in hospital length of stay without adverse impact on readmission rates. Additionally, the tool was associated with improvements in inpatient diabetes care and patient satisfaction.

Many factors contribute to patients not taking medicines as directed. Australian professional research papers often investigate compliance as an adjunct to other research goals. Consumer research looks at the broader range of factors and issues that might contribute to how consumers use their medicines. This research often identifies questions people say they would like to ask their doctors, such as 'What is the medicine for?' and 'What are the likely effects?'. Sometimes patients will forget to ask, are held back by language or social barriers or are reluctant to trouble a doctor. Effective communication with doctors helps consumers to use their medicines appropriately and this improves their satisfaction with treatments and health care providers.

No abstract